. To come up with these findings, researchers from Cleveland Clinic together with investigators at the Georgetown University Hospital in Washington DC analyzed more than 1 million subjects as well as their cannabis consumption patterns and the prevalence of hepatocellular carcinoma among them. They reported that current marijuana consumers are “55 percent less likely to have HCC compared to non-cannabis users.”